CAPRELSA 300 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400922066974
  • CIP7 2206697
  • CIS 69269825
  • Registration number EU/1/11/749

What the source publishes

Holder
ESTEVE PHARMACEUTICALS (ESPAGNE)
Active ingredients
VANDÉTANIB
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2012-02-14
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400922066974
{
  "cis": "69269825",
  "cip7": "2206697",
  "form": "comprimé pelliculé",
  "name": "CAPRELSA 300 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)",
  "cip13": "3400922066974",
  "holder": "ESTEVE PHARMACEUTICALS (ESPAGNE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "ESTEVE PHARMACEUTICALS (ESPAGNE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "3778.87",
  "authorisedOn": "2012-02-14",
  "compositions": [
    {
      "name": "VANDÉTANIB",
      "nature": "SA",
      "strength": "300 mg",
      "linkageNumber": "1",
      "substanceCode": "87461",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "3777.85",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "CAPRELSA 300 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "2013-08-01",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "VANDÉTANIB"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/11/749",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400922066974"